Common diabetes drug prevents the development of long COVID, study finds

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

Related Keywords

United States ,Carolyn Bramante ,Megan Craig ,National Institutes Of Health Center ,M Health Fairview ,Rainwater Charitable Foundation ,M Medical School ,Parsemus Foundation ,University Of Minnesota ,United Health Foundation ,Translational Sciences ,College Of Science ,Lancet Infectious Diseases ,Engineering Biomedical ,Fast Grants ,United Health Foundation This ,National Institutes ,National Center ,Advancing Translational Sciences ,Metformin ,Flood ,Hronic ,Clinical Trial ,Covid 19 ,Diabetes ,Heart ,Infectious Diseases ,Ivermectin ,Medical School ,Medicine ,Micron ,Placebo ,Public Health ,Research ,Herapeutics ,Virus ,